Progress in Pediatric Cardiology
Volume 25, Issue 1 , Pages 79-84 , April 2008

Peripartum cardiomyopathy: An update

  • Stacy D. Fisher

      Affiliations

    • Mid-Atlantic Cardiovascular Associates, Sinai Hospital of Baltimore, USA
    • Corresponding Author InformationCorresponding author. 1838 Greene Tree Road, Suite 535, Baltimore, MD 21208 USA. Tel.: +1 410 653 3923; fax: +1 410 653 1267.
    • ,
  • Amena Etherington

      Affiliations

    • Department of Internal Medicine, Sinai Hospital of Baltimore, USA
    • ,
  • David B. Schwartz

      Affiliations

    • Division of Maternal–Fetal Medicine, Department of Obstetrics and Gynecology, Sinai Hospital of Baltimore, USA
    • ,
  • Gail D. Pearson

      Affiliations

    • Heart Development and Structural Diseases Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, USA

References 

  1. Pearson GD, Veille JC, Rahimtoola S, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA. 2000;283(9):1183–1188
  2. Abboud J, Murad Y, Chen-Scarabelli C, et al. Peripartum cardiomyopathy: a comprehensive review. Int J Cardiol. 2007;118(3):295–303
  3. Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet. 2006;368(9536):687–693
  4. Ro RA, Frishman WH. Peripartum cardiomyopathy. Cardiol Rev. 2006;14(1):35–42
  5. Elkayam U, Akhter MW, Singh H, et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation. 2005;111(16):2050–2055
  6. Mielniczuk LM, Williams K, Davis DR, et al. Frequency of peripartum cardiomyopathy. Am J Cardiol. 2006;97(12):1765–1768
  7. Brar SS, Khan SS, Sandhu GK, et al. Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol. 2007;100(2):302–304
  8. Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2004. Natl Vital Stat Rep. 2006;55(1):1–101
  9. Fett JD, Christie LG, Carraway RD, Murphy JG. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc. 2005;80(12):1602–1606
  10. Sakata Y, Hoit BD, Liggett SB, et al. Decompensation of pressure-overload hypertrophy in Gαq-overexpressing mic. Circulation. 1998;97(15):1433–1435
  11. Hayakawa Y, Chandra M, Miao W, et al. Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Gq transgenic mic. Circulation. 2003;108(24):3036–3041
  12. Kunisada K, Tone E, Fujio Y, et al. Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. Circulation. 1998;98(4):346–352
  13. Hilfiker-Kleiner D, Kaminski K, Podewski E, et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell. 2007;128(3):589–600
  14. Podewski EK, Hilfiker-Kleiner D, Hilfiker A, et al. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy. Circulation. 2003;107(6):798–802
  15. Sliwa K, Forster O, Libhaber E, et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J. 2006;27(4):441–446
  16. Demakis JG, Rahimtoola SH, Sutton GC, et al. Natural course of peripartum cardiomyopathy. Circulation. 1971;44(6):1053–1061
  17. Hibbard JU, Lindheimer M, Lang RM. A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstet Gynecol. 1999;94(2):311–316
  18. Wake K, Takanishi T, Kitajima T, et al. Cardiac arrest during emergency cesarean section due to peripartum cardiomyopathy—a case report. Masui. 2003;52(10):1089–1091
  19. Fussell KM, Awad JA, Ware LB. Case of fulminant hepatic failure due to unrecognized peripartum cardiomyopathy. Crit Care Med. 2005;33(4):891–893
  20. Lui CY, Marcus FI, Sobonya RE. Arrhythmogenic right ventricular dysplasia masquerading as peripartum cardiomyopathy with atrial flutter, advanced atrioventricular block and embolic stroke. Cardiology. 2002;97(1):49–50
  21. Patel C, Shirali G, Pereira N. Left ventricular noncompaction mimicking peripartum cardiomyopathy. J Am Soc Echocardiogr. 2007;20(8):1009.e9–1009.e12
  22. Lipshultz SE, Colan SD, Gelber RD, et al. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med. 1991;324(12):808–815
  23. Steinherz LJ, Steinherz PG, Tan CT, et al. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA. 1991;266(12):1672–1677
  24. Adams MJ, Lipshultz SE. Pathophysiology of anthracycline-and radiation-associated cardiomyopathies: implications for screening and prevention. Pediatr Blood Cancer. 2005;44(7):600–606
  25. Berry GJ, Jordan M. Pathology of radiation and anthracycline cardiotoxicity. Pediatr Blood Cancer. 2005;44(7):630–637
  26. Gonzalez A, Fortuno MA, Querejeta R. Cardiomyocyte apoptosis in hypertensive cardiomyopathy. Cardiovasc Res. 2003;59(3):549–562
  27. Benlolo S, Lefoll C, Katchatouryan V, et al. Successful use of levosimendan in a patient with peripartum cardiomyopathy. Anesth Analg. 2004;98(3):822–824
  28. Benezet-Mazuecos J, de la Hera J. Peripartum cardiomyopathy: a new successful setting for levosimendan. Int J Cardiol. 2007;[Electronic publication ahead of print]
  29. Tandler R, Schmid C, Weyand M, Scheld HH. Case report: Novacor LVAD bridge to transplantation in peripartum cardiomyopathy. Eur J Cardio-thorac Surg. 1997;11:394–396
  30. Yang HS, Hong YS, Rim SJ, Yu SH. Extracorporeal membrane oxygenation in a patient with peripartum cardiomyopathy. Ann Thorac Surg. 2007;84:262–264
  31. Whitehead SJ, Berg CJ, Chang J. Pregnancy-related mortality due to cardiomyopathy: United States, 1991–1997. Obstet Gynecol. 2003;102(6):1326–1331
  32. Shariff S, Zaman KS. Prognostic factors at initial presentation in patients with peripartum cardiomyopathy. J Pak Med Assoc. 2003;53:297
  33. Chapa JB, Heiberger HB, Weinert L, et al. Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol. 2005;105(6):1303–1308
  34. Amos AM, Jaber WA, Russell SD. Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J. 2006;152(3):509–513
  35. Box LC, Hanak V, Arciniegas JG. Dual coronary emboli in peripartum cardiomyopathy. Texas Heart Inst J. 2004;31(4):442–444
  36. Dorbala S, Brozena S, Logsetty G, et al. Risk stratification of women with peripartum cardiomyopathy at initial presentation: a dobutamine stress echocardiography study. J Am Soc Echocardiogr. 2005;18(1):45–48
  37. Hu CL, Li YB, Zou YG, et al. Troponin T measurement can predict persistent left ventricular dysfunction in peripartum cardiomyopathy. Heart. 2007;93(4):488–490
  38. Elkayam U, Tummala PP, Rao K, et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med. 2001;344(21):1567–1571
  39. Fett JD, Murphy JG. Infant survival in Haiti after maternal death from peripartum cardiomyopathy. Int J Gynecol Obstet. 2006;94:135–136
  40. Romero R, Espinoza J, Kusanovic JP, et al. The role of inflammation and infection in preterm birth. Semin Reprod Med. 2007;25(1):21–39
  41. Lipshultz SE, Easley KA, Orav EJ, et al. Cardiovascular status of infants and children of women infected with HIV-1 (P(2)C(2) HIV): a cohort study. Lancet. 2002;360(9330):368–373
  42. Safirstein JG, Ro AS, Grandhi S, et al. Evaluation of classic risk factors in a new cohort of peripartum cardiomyopathy survivors. J Card Fail. 2007;13(6 Suppl):S154

PII: S1058-9813(07)00170-1

doi: 10.1016/j.ppedcard.2007.11.009

Progress in Pediatric Cardiology
Volume 25, Issue 1 , Pages 79-84 , April 2008

Article Tools